[Retracted] The Use of Cytotoxic Drugs as First Line Chemotherapy for EGFR (+) Nonsquamous NSCLC: A Network Meta-Analysis

<div>Histogram and area of SUCRA in PFS. The PFS indicator SUCRA values ranked CTX, cetuximab, icotinib, gefitinib, afatinib, and erlotinib in descending order. This demonstrates that erlotinib has the highest chance of achieving the best PFS, whereas CTX has the lowest.</div>

Disease Markers

fig6

Figure 6

Figure 6: [Retracted] The Use of Cytotoxic Drugs as First Line Chemotherapy for EGFR (+) Nonsquamous NSCLC: A Network Meta-Analysis 